Interleukin-1β and interleukin-1 receptor antagonist appear in grey matter additionally to white matter lesions during experimental multiple sclerosis.
Prins, Marloes
Interleukin-1β and interleukin-1 receptor antagonist appear in grey matter additionally to white matter lesions during experimental multiple sclerosis. [electronic resource] - PloS one 2013 - e83835 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1932-6203
10.1371/journal.pone.0083835 doi
Animals
Disease Models, Animal
Encephalomyelitis, Autoimmune, Experimental--genetics
Gene Expression Regulation
Gray Matter--metabolism
Interleukin 1 Receptor Antagonist Protein--genetics
Interleukin-1beta--genetics
Male
Multiple Sclerosis--genetics
Protein Transport
RNA, Messenger--genetics
Rats
Recurrence
White Matter--metabolism
Interleukin-1β and interleukin-1 receptor antagonist appear in grey matter additionally to white matter lesions during experimental multiple sclerosis. [electronic resource] - PloS one 2013 - e83835 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1932-6203
10.1371/journal.pone.0083835 doi
Animals
Disease Models, Animal
Encephalomyelitis, Autoimmune, Experimental--genetics
Gene Expression Regulation
Gray Matter--metabolism
Interleukin 1 Receptor Antagonist Protein--genetics
Interleukin-1beta--genetics
Male
Multiple Sclerosis--genetics
Protein Transport
RNA, Messenger--genetics
Rats
Recurrence
White Matter--metabolism